论文部分内容阅读
目的:分析阿奇霉素分散片联合氨溴索治疗慢性阻塞性肺病急性加重期的疗效。方法:将自2014年9月至2016年3月间在我院治疗的103例慢性阻塞性肺病急性加重期患者为研究对象,将患者分组后采用不同的药物进行治疗,并对患者治疗前后的评价指标内容进行对比。结果:采用阿奇霉素分散片联合氨溴索治疗的观察组的动脉血气指标(SpO2、PaO2、PaCO2、pH值)明显优于采用氨溴索治疗的对照组,P<0.05;两组患者治疗后的指标值较治疗前均有显著改善,P<0.05。均有统计学意义。结论:对慢性阻塞性肺病急性加重期采用阿奇霉素分散片联合氨溴索治疗能获得更好的临床效果,值得临床推广应用。
Objective: To analyze the curative effect of azithromycin dispersible tablets and ambroxol on acute exacerbation of chronic obstructive pulmonary disease. Methods: From September 2014 to March 2016 in our hospital treated 103 cases of patients with acute exacerbation of chronic obstructive pulmonary disease patients were divided into groups after the use of different drugs for treatment, and before and after treatment of patients Evaluation index content comparison. Results: Arterial blood gas indexes (SpO2, PaO2, PaCO2, pH) of the observation group treated with azithromycin dispersible tablets combined with ambroxol were significantly better than those of the control group treated with ambroxol (P <0.05). After treatment, Index values were significantly improved than before treatment, P <0.05. All have statistical significance. Conclusion: Azithromycin dispersible tablets combined with ambroxol in acute exacerbation of chronic obstructive pulmonary disease can achieve better clinical results, which is worthy of clinical application.